BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1319777)

  • 1. Activation of the tyrosine kinase receptor is not sufficient for the full biological activity of bFGF.
    Isacchi A; Bergonzoni L; Statuto M; Chiesa R; Rusnati M; Presta M; Ragnotti G; Sarmientos P
    EXS; 1992; 61():101-6. PubMed ID: 1319777
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
    Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
    Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.
    Isacchi A; Statuto M; Chiesa R; Bergonzoni L; Rusnati M; Sarmientos P; Ragnotti G; Presta M
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2628-32. PubMed ID: 1849269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
    Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
    J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two new hydrophobic residues on basic fibroblast growth factor important for fibroblast growth factor receptor binding.
    Zhu H; Ramnarayan K; Menzel P; Miao Y; Zheng J; Mong S
    Protein Eng; 1998 Oct; 11(10):937-40. PubMed ID: 9862214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of basic fibroblast growth factor with digoxigenin: a nonradioactive probe for biochemical and cytological applications.
    Gleizes PE; Noaillac-Depeyre J; Gas N
    Anal Biochem; 1994 Jun; 219(2):360-7. PubMed ID: 8080093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
    Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
    Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
    Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
    Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, recombinant expression, and characterization of basic fibroblast growth factor.
    Thompson SA; Protter AA; Bitting L; Fiddes JC; Abraham JA
    Methods Enzymol; 1991; 198():96-116. PubMed ID: 1857242
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells.
    Sato Y; Abe M; Takaki R
    Biochem Biophys Res Commun; 1990 Oct; 172(2):595-600. PubMed ID: 2173572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
    Klint P; Kanda S; Kloog Y; Claesson-Welsh L
    Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli.
    Bergonzoni L; Caccia P; Cletini O; Sarmientos P; Isacchi A
    Eur J Biochem; 1992 Dec; 210(3):823-29. PubMed ID: 1336458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence.
    Presta M; Gualandris A; Urbinati C; Rusnati M; Coltrini D; Isacchi A; Caccia P; Bergonzoni L
    Growth Factors; 1993; 9(4):269-78. PubMed ID: 8148156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library.
    Yayon A; Aviezer D; Safran M; Gross JL; Heldman Y; Cabilly S; Givol D; Katchalski-Katzir E
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10643-7. PubMed ID: 7504274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of fibroblast growth factor-related transforming gene hst-1.
    Yoshida T; Miyagawa K; Sakamoto H; Sugimura T; Terada M
    Methods Enzymol; 1991; 198():124-38. PubMed ID: 1830360
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
    Mansukhani A; Dell'Era P; Moscatelli D; Kornbluth S; Hanafusa H; Basilico C
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3305-9. PubMed ID: 1373495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells.
    Presta M; Rusnati M; Urbinati C; Tanghetti E; Statuto M; Pozzi A; Gualandris A; Ragnotti G
    EXS; 1992; 61():205-9. PubMed ID: 1617232
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells.
    Slevin M; Kumar S; He X; Gaffney J
    Int J Cancer; 1999 Jul; 82(3):412-23. PubMed ID: 10399959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells.
    Isacchi A; Bergonzoni L; Statuto M; Rusnati M; Chiesa R; Caccia P; Sarmientos P; Presta M; Ragnotti G
    Ann N Y Acad Sci; 1991; 638():369-77. PubMed ID: 1664689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.